The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex complicated chemical process. Initial routes focused on peptide fragment coupling, utilizing solid-phase https://ambervrgw398020.idblogz.com/41051135/creation-and-investigation-uses-of-retatrutide